Abstract:ABSTRACT Recombinant (r)AAV2.5T was selected from the directed evolution of an adeno-associated virus (AAV) capsid library in the human airway epithelium (HAE). The capsid gene of rAAV2.5T is a chimera of the N-terminal unique coding sequence of AAV2 VP1 unique (VP1u) and the VP2- and VP3-coding sequences of AAV5 with a single amino acid mutation of A581T. We conducted two rounds of genome-wide CRISPR guide (g)RNA library screening for host factors limiting rAAV2.5T transduction in HeLa S3 cells. The screening identified several genes that are critical for rAAV2.5T, including the previously reported genes KIAA0319L , TM9SF2 , VPS51 , and VPS54 , as well as a novel gene WDR63 . We verified the role of KIAA0319L and WDR63 in rAAV2.5T transduction of polarized HAE by utilizing CRISPR gene knockouts. Although KIAA0319L, a proteinaceous receptor for multiple AAV serotypes, played an essential role in rAAV2.5T transduction of polarized HAE either from the apical or basolateral side, our findings demonstrated that the internalization of rAAV2.5T was independent of KIAA0319L. Importantly, we confirmed that WDR63 is an important player in rAAV2.5T transduction of HAE while not being involved in vector internalization and nuclear entry. Furthermore, we identified that the basal stem cells of HAE can be significantly transduced by rAAV2.5T. IMPORTANCE The essential steps of successful gene delivery by recombinant adeno-associated viruses (rAAVs) include vector internalization, intracellular trafficking, nuclear import, uncoating, double-stranded (ds)DNA conversion, and transgene expression. rAAV2.5T has a chimeric capsid of AAV2 VP1u and AAV5 VP2 and VP3 with the mutation A581T. Our investigation revealed that KIAA0319L, the multiple AAV serotype receptor, is not essential for vector internalization but remains critical for efficient vector transduction to human airway epithelia. Additionally, we identified that a novel gene WDR63 , whose cellular function is not well understood, plays an important role in vector transduction of human airway epithelia but not vector internalization and nuclear entry. Our study also discovered the substantial transduction potential of rAAV2.5T in basal stem cells of human airway epithelia, underscoring its utility in gene editing of human airways. Thus, the knowledge derived from this study holds promise for the advancement of gene therapy in the treatment of pulmonary genetic diseases.

The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice

Glycan Binding Avidity Determines the Systemic Fate of Adeno-Associated Virus Type 9

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Transduction Efficiencies of Novel AAV Vectors in Mouse Airway Epithelium in Vivo and Human Ciliated Airway Epithelium in Vitro

Targeting transgene to the heart and liver with AAV9 by different promoters

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Glycan binding avidity determines the systemic fate of adeno-2 associated virus 9 3 4 5

Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood–brain barrier in rodents and primates

Non-canonical amino acid incorporation into AAV5 capsid enhances lung transduction in mice

Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice

Enhancing transduction efficiency of adeno-associated virus 9 by cell line engineering: implication for gene therapy potency assay

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery

Identification of host essential factors for recombinant AAV transduction of the polarized human airway epithelium

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1

Enhancing transduction of the liver by adeno-associated viral vectors

A Comprehensive Atlas of AAV Tropism in the Mouse

Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors

Tissue and cell-type-specific transduction using rAAV vectors in lung diseases

AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery

AAV-DJ is Superior to AAV9 for Targeting Brain and Spinal Cord, and De-Targeting Liver Across Multiple Delivery Routes in Mice

Identification of new AAV vectors with enhanced blood-brain barrier penetration efficiency via organ-on-a-chip